Bezos family donated $35 million to Fred Hutch
On Mar. 30, 2017, the Fred Hutchinson Cancer Research Center announced that the Bezos family had donated $35…
Genentech drug Ocrevus (ocrelizumab) was approved
On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…
University of Alberta researchers announced they had discovered the protein Rab32 in the brains of MS patients.
On Mar. 25, 2017, University of Alberta researchers announced they had discovered the protein Rab32 in the brains…
the Siteman Cancer Network Center was launched
On Mar. 3, 2017, Siteman Cancer Center launched the Siteman Cancer Network to improve the health of individuals…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Cleveland Clinic opened new cancer Center
On Feb. 16, 2017, the new Cleveland Clinic Taussig Cancer Center began welcoming patients. The 377,000-square-foot facility, estimated…
CDC published the 2017 US recommended immunization schedules for 0 through 18 years
On Feb. 10, 2017, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Children…
CDC published the 2017 U.S. recommended adult immunization schedule
On Feb. 10, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published the 2017 U.S. recommended…
The Bill & Melinda Gates Foundation pledged $279 million to University of Washington’s Institute for Health Metrics and Evaluation
On Jan. 25, 2017, the Bill & Melinda Gates Foundation pledged $279 million to the University of Washington’s…
Scripps Research Institute scientists created first stable semisynthetic organism
On Jan. 23, 2017, scientists at The Scripps Research Institute (TSRI) announced the development of the first stable…
PharmAthene and Altimmune announced merger to create immunotherapeutics company targeting infectious diseases
On Jan. 19, 2017, PharmAthene and Altimmune, a privately-held immunotherapeutics company targeting infectious diseases, announced an agreement for…
Canada Foundation awarded $6 million for Innovation Metabolomics Innovation Centre at the University of Alberta
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
Abbott completed acquisition of St Jude Medical for $25 billion
On Jan. 4, 2017, Abbott announced it had completed the acquisition of St. Jude Medical for $25 billion….
First drug approved by the FDA for treatment of canine lymphoma
On Jan. 3, 2017, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) announced the conditional…
BioXcel therapeutics was founded
In 2017, BioXcel Therapeutics was founded in New Haven, Connecticut as a clinical-stage biopharmaceutical company that utilizes novel…
SpringWorks Therapeutics was founded
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
Biotechnology | Life Science History | Life Science News | Medicine | Non-Profit Research | Therapeutics
The Vanderbilt Microbiome Initiative was founded
In 2017, the Vanderbilt Microbiome Initiative (VMI) at Vanderbilt University was established bringing together an unprecedented group of…
The Asian longhorned tick found in Virginia
In 2017, Virginia Tech veterinary pathologist Kevin Lahmers identified the Asian longhorned tick as the source of seven…
Genomic sequencing illuminated Shigella outbreaks in California
On Dec. 23, 2016, researchers at University of California (UC) Davis and California Department of Public Health announced…
Biotechnology | Disease | Life Science News | NIH | Therapeutics | Vaccine
Medigen Vaccines Biologics teamed with U.S. CDC to develop VLP vaccine for Dengue disease
On Dec. 14, 2016, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
Bristol-Myers Squibb announced closure of Seattle’s ZymoGenetics operation
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Medicine | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
Celgene, Dana-Farber, and University of Arkansas established the Myeloma Genome Project
On Dec. 3, 2016, Celgene, Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences announced the…
Selexys Pharmaceuticals Corp was acquired by Novartis
On Nov. 21, 2016, Novartis announced it had acquired Selexys Pharmaceuticals Corp, a Oklahoma City-based company that specialized…
FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age
On Nov. 18, 2016, the U.S. Food and Drug Administration (FDA) approved extending the age range for use…
Artificial Intelligence | Biotechnology | Disease | Genomics | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Washington University invested $25 million in imaging sciences
On Nov. 18, 2016, Washington University in St. Louis launched a bold, $25 million initiative over the next…
Biotechnology | Diagnostics | Disease | Life Science News | Medicine | Therapeutics | Women's Health
The U.S. Surgeon General issued landmark Report on Alcohol, Drugs, and Health
On Nov. 17, 2016, the U.S. Surgeon General Dr. Vivek Murthy issued a landmark Report on Alcohol, Drugs,…
Biotechnology | CRISPR | Disease | Genomics | Life Science News | NIH | Non-Profit Research | Therapeutics
The National Institutes of Health issued guidelines for DNA splicing
On Nov. 15, 2016, the National Institutes of Health (NIH) issued guidelines for DNA splicing. The guidelines set…
Biotechnology | CDC | Disease | HIV | Life Science News | Non-Profit Research | Pharmaceutical | Vaccine
CDC published ACIP recommendations for use of meningococcal conjugate vaccines in HIV-infected persons
On Nov. 4, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
Fred Hutch opened first-of-its kind Bezos Family Immunotherapy Clinic
On Nov. 1, 2016, the Fred Hutchinson Cancer Research Center announced the opening of the Bezos Family Immunotherapy…
Roswell Park study brought Cuban lung cancer vaccine to U.S. Patients
On Oct. 27, 2016, Roswell Park Cancer Institute announced it had received authorization from the U.S. Food and…
Biotechnology | Chemical | Disease | FDA | Life Science News | Oncology | Therapeutics
Genentech drug Tecentriq (atezolizumab) was approved
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…